The Biosimilars Forum has welcomed a piece of bipartisan legislation introduced by US senators Maria Cantwell and Chuck Grassley, which would crack down on certain pharmacy benefit manager business practices that the Forum believes have a negative impact on the biosimilars industry.
Biosimilars Forum Welcomes PBM Transparency Act
US Proposals Would See Spread Pricing Outlawed And Rebates Disclosed
Senators Maria Cantwell and Chuck Grassley have introduced a bill which would limit pharmacy benefit managers’ ability to engage in “unfair and deceptive” business practices, a move which has been welcomed by the Biosimilars Forum.
